Works matching AU Virk, Shakeel


Results: 15
    1
    2
    3
    4
    5
    6

    Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 213, n. 1, p. 51, doi. 10.1007/s10549-025-07749-9
    By:
    • Chapman, Judith-Anne W.;
    • Bayani, Jane;
    • SenGupta, Sandip;
    • Bartlett, John M. S.;
    • Piper, Tammy;
    • Quintayo, Mary Anne;
    • Virk, Shakeel;
    • Goss, Paul E.;
    • Ingle, James N.;
    • Ellis, Matthew J.;
    • Sledge, George W.;
    • Budd, G. Thomas;
    • Rabaglio, Manuela;
    • Ansari, Rafat H.;
    • Tozer, Richard;
    • D'Souza, David P.;
    • Chalchal, Haji;
    • Spadafora, Silvana;
    • Stearns, Vered;
    • Perez, Edith A.
    Publication type:
    Article
    7

    Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).

    Published in:
    Breast Cancer Research & Treatment, 2017, v. 164, n. 3, p. 571, doi. 10.1007/s10549-017-4273-x
    By:
    • Ho, Diep;
    • Huang, Jessica;
    • Chapman, Judith-Anne;
    • Leitzel, Kim;
    • Ali, Suhail;
    • Shepherd, Lois;
    • Parulekar, Wendy;
    • Ellis, Catherine;
    • Crescnzo, Rocco;
    • Zhu, Liting;
    • Virk, Shakeel;
    • Nomikos, Dora;
    • Aparicio, Samuel;
    • Gelmon, Karen;
    • Carney, Walter;
    • Lipton, Allan
    Publication type:
    Article
    8
    9
    10
    11

    Higher serum PD‐L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 22, p. 4859, doi. 10.1002/cncr.33149
    By:
    • Moku, Prashanth;
    • Shepherd, Lois;
    • Ali, Suhail M.;
    • Leitzel, Kim;
    • Parulekar, Wendy R.;
    • Zhu, Liting;
    • Virk, Shakeel;
    • Nomikos, Dora;
    • Aparicio, Samuel;
    • Gelmon, Karen;
    • Drabick, Joe;
    • Cream, Leah;
    • Halstead, E. Scott;
    • Umstead, Todd M.;
    • Mckeone, Dan;
    • Polimera, Hyma;
    • Maddukuri, Ashok;
    • Ali, Aamnah;
    • Nagabhairu, Vinod;
    • Poulose, Joyson
    Publication type:
    Article
    12
    13
    14
    15

    Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 6, p. 1334, doi. 10.1080/10428194.2020.1713318
    By:
    • Chen, Lina;
    • Tyryshkin, Kathrin;
    • Moore, Alison;
    • Scott, David W.;
    • Steidl, Christian;
    • Li, Yi;
    • Shepherd, Lois E.;
    • Rauh, Michael;
    • Deng, Lan;
    • Good, David;
    • Virk, Shakeel;
    • Chen, Bingshu E.;
    • Crocker, Susan;
    • Baetz, Tara;
    • LeBrun, David P.
    Publication type:
    Article